PTEN and prostate neoplasm: Phosphatase and tensin homolog (PTEN) is one of the most commonly inactivated tumour suppressor genes in PCa, with around 20% of primary prostate tumours exhibiting aberrations in PTEN, rising to approximately 40% of mCRPC cases (Robinson et al. 2015).